Clinical Trial Update: Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity

View source ↗

Summary

An ongoing clinical study assessing the use of FibroScan to diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) in obese Chinese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• FibroScan

Snippet

Sponsor: The Third People's Hospital of Chengdu | Conditions: Fatty Liver Disease | Status: RECRUITING